Your browser doesn't support javascript.
loading
Statewide efforts to address the opioid epidemic: Results from a national survey of single state agencies.
Estrada, Miguel Antonio G; Abraham, Amanda J; Andrews, Christina M; Grogan, Colleen M.
Afiliação
  • Estrada MAG; Department of Public Administration and Policy, School of Public and International Affairs, University of Georgia, Athens, GA, USA. Electronic address: miguelantonio.estrada@uga.edu.
  • Abraham AJ; Department of Public Administration and Policy, School of Public and International Affairs, University of Georgia, Athens, GA, USA.
  • Andrews CM; Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.
  • Grogan CM; Crown Family School of Social Work, Policy, and Practice, University of Chicago, Chicago, IL, USA.
J Subst Use Addict Treat ; 160: 209309, 2024 May.
Article em En | MEDLINE | ID: mdl-38336265
ABSTRACT

BACKGROUND:

Single State Agencies (SSAs) are at the forefront of efforts to address the nation's opioid epidemic, responsible for allocating billions of dollars in federal, state, and local funds to ensure service quality, promote best practices, and expand access to care. Federal expenditures to SSAs have more than tripled since the early years of the epidemic, yet, it is unclear what initiatives SSAs have undertaken to address the crisis and how they are financing these efforts.

METHODS:

This study used data from an internet-based survey of SSAs, conducted by the University of Chicago Survey Lab from January to December 2021 (response rate of 94 %). The survey included a set of 14 items identifying statewide efforts to address the opioid epidemic and six funding sources. We calculated the percentage of SSAs that supported each statewide effort and the percentage of SSAs reporting use of each source of funding across the 14 statewide efforts.

RESULTS:

Treatment of opioid-related overdose figured most prominently among statewide efforts, with all SSAs providing funding for naloxone distribution and all but one SSA supporting naloxone training. Recovery support services, Project ECHO, and Hub and Spoke models were supported by the vast majority of SSAs. Statewide efforts related to expanding access to medications for opioid use disorder (MOUD) received somewhat less support, with 45 % of SSAs supporting mobile methadone/MOUD clinics/programs and 70 % supporting buprenorphine in emergency departments. A relatively low proportion of SSAs (54 %) provided support for syringe services programs. State Opioid Response (SOR) funds were the most common funding source reported by SSAs (57 % of SSAs), followed by block grant funds (19 %) and other state funding (15 %).

CONCLUSION:

Results highlight a range of SSA efforts to address the nation's opioid epidemic. Limited adoption of efforts to expand access to MOUD and harm reduction services may represent missed opportunities. The uncertainty over reauthorization of the SOR grant post-2025 also raises concerns over sustainability of funding for many of these statewide initiatives.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Epidemia de Opioides Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Epidemia de Opioides Idioma: En Ano de publicação: 2024 Tipo de documento: Article